Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home

White Papers Directory

Latest White Papers
D6B Fitzmill® Comminutor
21 September 2012 | By Medelpharm
FitzPatrick introduces the model D6B Comminutor
Production & Manufacturing > Process & Production > White Papers
Darbox UN Packaging Company Brochure
09 January 2013 | By Darbox
Find out about Darbox UN-certified heavy-duty plastic containers for API's, ingredients, intermediates, tablets, powders and capsules and why you can save by using nestable square containers.
White Papers
Darbox UN Packaging Company Presentation
09 January 2013 | By Darbox
Use Darbox UN-certified high-quality containers to package your bulk powders, granules, tablets, capsules, flakes and more. Why transport empty volume? Save on storage and warehouse space - maximize the pallet footprint.
White Papers
Dedicated Pharmaceutical Product Range
03 November 2010 | By Avery Dennison
Avery Dennison's high-quality pharmaceutical product range has been developed to meet industry standards for mandrel performance, low migration characteristics and compliance. Typical applications for this product range include OTC, prescription medicines and a range of other medicament packaging. Accordingly, the product range is designed to meet the pharmaceutical packaging standards.
White Papers
Delta 2000 - Product Range Brochure
16 January 2013 | By Delta 2000
Our products are the result of the full involvemnet of every department, from sales to production, continuous investments in investments.
Production & Manufacturing > Manufacturing > White Papers
Desktop Applications
18 November 2010 | By ChemAxon
All the performance of our enterprise and discovery cheminformatics toolkits on your desktop.
White Papers
Desktop SEM Imaging in the Development of a Radioablation Device
13 June 2011 | By Phenom World
Radioembolization is a type of internal radiation therapy developed for the treatment of liver tumors. Liver tumors rely almost exclusively on the hepatic artery for their blood supply. In radioembolization, radioactive particles are selectively administered to the hepatic artery, leading to a selective accumulation of these particles around the tumor. Consequently, the tumor tissue is irradiated, whilst sparing the healthy liver tissue.
White Papers
Device Driver and Software Interface Programming
08 November 2012 | By beyontics
Data transfer from equipment and programs to your CDS: In the area of customer specific solutions beyontics helps you with generating equipment and system connections to your CDS. No matter if a data transfer between your LIMS and your CDS or the connection of any kind of device (e.g. balances or pH meters), the beyontics software development provides efficient and reliable solutions for your lab.
Automation > Laboratory Instrumentation > White Papers
Digital ECG
04 October 2011 | By CoreLab Partners
CoreLab Partners is internationally recognized as a leading provider of ECG services with more than 25 years of experience in the collection, management, and analysis of ECGs. With experience working alongside the ICH and FDA in the development of regulatory and industry guidelines, CoreLab Partners is best positioned to aid you in the design and conduct of your next cardiac safety and efficacy study.
White Papers
Direct analysis of biogenic amines in food by HILIC-MS
09 May 2012 | By Tosoh Bioscience
Biogenic amines are present in protein-rich food such as fish, meat or milk. Their concentration increases during food decomposition. The reasons to monitor biogenic amines in food products are to determine that the food is suitable for consumption and to establish appropriate storage conditions.
Drug Research > Drug Discovery & Development > White Papers
Discovery Innovation – Productive Partnering for Shared Success
22 September 2011 | By Kinapse
Phase II clinical development has traditionally been considered the ‘sweet spot’ for big pharma partnering deals. However our recent analysis reveals that discovery and early-stage clinical alliances are of increasing importance to big pharma’s long-term business strategy. This paper highlights the shifting industry trends responsible for the growth in earlier-stage partnering and describes how key stakeholders in the discovery space are evolving. We discuss the implications of this changing landscape for big pharma, and outline the new competences required to maximize value, mitigate risks and ultimately deliver new treatments to market.
White Papers
Discovery Metrics – Creating the Right Balance
22 September 2011 | By Kinapse
Metrics can be powerful tools for driving performance, but the measurement of effort and output in Discovery organisations is often felt to be in fundamental conflict with the need for the creative, unconstrained culture required to drive innovation. In addition, many would argue that Discovery metrics largely fail to yield benefits. This paper explores the reasons behind that, and looks at an approach to defining metrics that are ‘fit for purpose’.
White Papers
DocCompliance Datasheet
12 May 2011 | By QUMAS
QUMAS DocComplianceTM is the cornerstone of the QUMAS Compliance PlatformTM. As an off-the-shelf web-based regulatory content management system, DocCompliance ensures enterprise-wide consistency and compliance. The solution enables organizations to create, manage, and securely store documents, using built in password policies to protect against unauthorized access. It contains full support for Electronic Signatures as per FDA 21 CFR Part 11 requirements. Best practice document management workflows ensure that the correct content is created, reviewed, approved, consumed, distributed and retired. It encourages optimum content management through built in best practices. Flexible configuration enables you to easily mirror your existing organizational structures and practices, and the intuitive user-interface ensures ease-of-use for all end users. DocCompliance can be used in conjunction with MyQUMASTM, which provides access to the full capabilities of the QUMAS Compliance platform including flexible business process management, learning management, business intelligence and content collaboration.
White Papers
Document Compliance Management
03 November 2010 | By Brainloop
A DCM system covers the entire lifecycle of a document with no gaps. As a consequence, the document always remains under the system's watchful eye, even when it is opened, edited or stored on the desktop.
White Papers
Dokumeds Company Brochure
18 October 2011 | By DOKUMEDS
Download our full company brochure here.
White Papers
DRAmanager™: Planning and Tracking of Drug Regulatory Activities
13 September 2010 | By EXTEDO
DRAmanager ensures the fast and smooth functioning of creating and maintaining product and device information and associated activities in accordance with the pharmaceutical, medical and health-related government and regulatory bodies around the world. DRAmanager is a standardized and open software solution for the management of pharmaceutical product information, medicinal product information, medical device information and associated regulatory tasks.
White Papers
Drug Delivery Technology, Alitra™
15 December 2010 | By Echo Pharmaceuticals
Our business activities are related to our isolation technology of API’s, our DDT Alitra™ and pharmaceutical evaluation of the selected compounds.
Drug Research > Drug Delivery > White Papers
Drug Safety Solutions
09 October 2012 | By Pierrel Research
The safety of medicines is an essential part of patient safety. The rapidly increasing scrutiny on drug safety issues, and an increasing number of regulations and risk management commitments have led to increased safety data collection, analysis and regulatory surveillance, which in turn have increased costs.
Contract Research & Services > Contract Research > White Papers
Dual Ion Source DUIS-2020 for Simultaneous ESI and APCI Measurement
03 March 2011 | By Shimadzu PBR
In LCMS measurement, the ionization mode is selected depending on the polarity of the target compounds. For example, Electrospray Ionization (ESI) is generally selected for analysis of high-polarity compounds which are typically found in drugs and pesticides, while Atmospheric Pressure Chemical Ionization (APCI) is selected for compounds having lower polarity.
White Papers
Duolink - Discover More About Proteins and Protein Interactions
03 November 2010 | By Olink Bioscience
The Duolink® approach provides new insights into proteins and protein interactions. For the first time, individual proteins, their interactions and modifications, can be accurately and objectively quantified in unmodified cells and tissues. For more information please download this free brochure.
White Papers
DXA Services
04 October 2011 | By CoreLab Partners
Dual energy X-ray absorptiometry (DXA) is an efficient, noninvasive, low-radiation dose measurement of bone mineral content (BMC), bone mineral density (BMD), and total body composition (fat and fat-free mass). It's currently the most common imaging tool used to determine BMD for disease processes such as osteoporosis. DXA offers low-radiation dosing (1/10 of the typical chest X-ray), rapid scan time, and ease of use. These distinctive attributes make DXA widely popular in the clinical research arena especially in trials employing bone density as a safety or efficacy endpoint.
White Papers
See all White Papers